Renagen DTX
On sale on the US market (according to the DSLD)
Metagenics, food supplement from the US market
Renagen DTX (Metagenics), a food supplement au code-barres 755571910998, is described by its US market label. If sold in France, it would be subject to 1 point of French or European regulation, detailed below. Doses of folates are not compared: their US units depend on the form. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 20 mg a day according to the label (at most 2 servings a day), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
Source: French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), arrêté du 9 mai 2006, annexe III.
- À vérifier
Vitamine B6: up to 20 mg a day according to the label, above the tolerable upper intake level from EFSAEuropean Food Safety Authority. for adults (12 mg a day). The EFSA reference covers total daily intake, from food and supplements.
Source: EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), limite supérieure de sécurité (UL).
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Metagenics
- Barcode
- 755571910998
- Form
- Capsule
- One serving
- 1 vegetarian capsule
- Servings
- up to 2 servings per day
- Other ingredients (in English, as written)
- Hydroxypropylmethylcellulose, Sodium Copper Chlorophyllin, Gellan Gum, Microcrystalline Cellulose, Magnesium Stearate
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Vitamin B6 | Vitamin | 10 mg |
| Metafolin | Vitamin | 680 µg DFE (dietary folate equivalent) |
| Vitamin B12 | Vitamin | 125 µg |
| Cordyceps Mycelium Extract | Plant | 200 mg |
| Cordycepic Acid | Other substance | 8 mg |
| Adenosine | Other substance | 0.5 mg |
| Chinese Salvia | Plant | 200 mg |
| N-Acetylcysteine | Other substance | 200 mg |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: Renagen DTX
Entered into DSLD on 24 March 2020. Withdrawn from the US market on 27 December 2019 (according to the DSLD).- Active ingredient added : Folate (400 mcg)
- Active ingredient removed : Adenosine (0.5 mg)
- Active ingredient removed : Cordycepic Acid (8 mg)
- Active ingredient removed : Metafolin (680 mcg DFE)
Official label: Renagen DTX
Entered into DSLD on 24 March 2020. Withdrawn from the US market on 7 September 2022 (according to the DSLD).- Active ingredient removed : Adenosine (0.5 mg)
- Active ingredient removed : Cordycepic Acid (8 mg)
- Same quantity, different name: Folate in this version; Metafolin on the displayed label (680 mcg DFE)
Official label: Renagen DTX
Entered into DSLD on 22 December 2019. Withdrawn from the US market on 27 December 2019 (according to the DSLD).- Active ingredient added : Folate (400 mcg)
- Active ingredient removed : Adenosine (0.5 mg)
- Active ingredient removed : Cordycepic Acid (8 mg)
- Active ingredient removed : Metafolin (680 mcg DFE)
Official label: Renagen DTX
Entered into DSLD on 25 November 2013. Withdrawn from the US market on 24 October 2019 (according to the DSLD).- Active ingredient added : Folate (0.4 mg)
- Active ingredient removed : Metafolin (680 mcg DFE)
- Different unit, without conversion : Adenosine: quantity not stated in this version; 0.5 mg on the displayed label
- Different unit, without conversion : cordycepic acid: quantity not stated in this version; 8 mg on the displayed label
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- N-Acetylcysteine
Read the warning, when it applies and the studies cited
N-ACETYL-L-CYSTEINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney stones (Fauci et al. 1998; Mårtensson et al. 1990).
Sources cited by Health Canada (2)
- Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DI, Hauser SL and Longo DL, editors. Harrison's Principles of Internal Medicine, 14th edition. Toronto (ON): McGraw-Hill Health Professions Division; 1998.
- Mårtensson J, Denneberg T, Lindell Å, Textorius O. Sulfur amino acid metabolism in cystinuria : A biochemical and clinical study of patients. Kidney International 1990;37:143-149. PubMed
Contraindications
Do not use if you are taking antibiotics or nitroglycerin (Repchinsky 2008; Cederlund and Märdh 1993; Parry and Neu 1977; Ardissino et al. 1997).
Sources cited by Health Canada (4)
- Ardissino D, Merlini PA, Savonitto S, Demicheli G, Zanini P, Bertocchi F, Falcone C, Ghio S, Marinoni G, Montemartini C, Mussini A. Effect of transdermal nitroglycerin or N- acetylcysteine, or both, in the long-term treatment of unstable angina pectoris. Journal of the American College of Cardiology 1997;29(5):941-947. PubMed Randomised trial
- Cederlund H, Märdh PA. Antibacterial activities of non-antibiotic drugs. Journal of Antimicrobial Chemotherapy 1993;32:355-365. PubMed Review article
- Parry MF, Neu HC. Effect of N-acetylcysteine on antibiotic activity and bacterial growth in vitro. Journal of Clinical Microbiology 1977;5(1);58-61.
- Repchinsky C, editor. Compendium of Pharmaceuticals and Specialties. The Canadian Drug Reference for Health Professionals. Ottawa (ON): Canadian Pharmacists Association; 2008.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Metagenics
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Renagen DTX (Metagenics): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/755571910998-renagen-dtx-metagenics, updated 23 August 2023.